🇺🇸 FDA
Patent

US 11091516

Synthetic binder of breast cancer stem cells

granted A61KA61K33/242A61K38/00

Quick answer

US patent 11091516 (Synthetic binder of breast cancer stem cells) held by The Board of Regents of the University of Texas System expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K33/242, A61K38/00, A61K41/0052, A61K45/06